Денсаулық сақтау экономикасы

Economic sector focused on health

The healthcare industry (also called the medical industry or health economy) is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive, rehabilitative, and palliative care. It encompasses the creation and commercialization of products and services conducive to the preservation and restoration of well being. The contemporary healthcare sector comprises three fundamental facets, namely services, products, and finance. It can be further subdivided into numerous sectors and categories and relies on interdisciplinary teams of highly skilled professionals and paraprofessionals to address the healthcare requirements of both individuals and communities. The healthcare industry is one of the world's largest and fastest growing industries. Consuming over 10 percent of gross domestic product (GDP) of most developed nations, health care can form an enormous part of a country's economy. U. S. healthcare spending grew 2.7 percent in 2021, reaching $4.3 trillion or $12,914 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 18.3 percent. The per capita expenditure on health and pharmaceuticals in OECD countries has steadily grown from a couple of hundred in the 1970s to an average of US$4'000 per year in current purchasing power parities.

A healthcare provider is an institution (such as a hospital or clinic) or person (such as a physician, nurse, allied health professional or community health worker) that provides preventive, curative, promotional, rehabilitative or palliative care services in a systematic way to individuals, families or communities. The World Health Organization estimates there are 9.2 million physicians, 19.4 million nurses and midwives, 1.9 million dentists and other dentistry personnel, 2.6 million pharmacists and other pharmaceutical personnel, and over 1.3 million community health workers worldwide, making the health care industry one of the largest segments of the workforce. The medical industry is also supported by many professions that do not directly provide health care itself, but are part of the management and support of the health care system. The incomes of managers and administrators, underwriters, and medical malpractice attorneys, marketers, investors, and shareholders of for profit services, all are attributable to health care costs. In 2017, healthcare costs paid to hospitals, physicians, nursing homes, diagnostic laboratories, pharmacies, medical device manufacturers, and other components of the healthcare system, consumed 17.9 percent of the gross domestic product (GDP) of the United States, the largest of any country in the world. It is expected that the health share of the Gross domestic product (GDP) will continue its upward trend, reaching 19.9 percent of GDP by 2025. In 2001, for the OECD countries the average was 8.4 percent with the United States (13.9%), Switzerland (10.9%), and Germany (10.7%) being the top three. US health care expenditures totaled US$2.2 trillion in 2006. The government does not ensure all inclusive health care to every one of its residents. However, certain freely supported healthcare programs help to accommodate a portion of people who are elderly, disabled, or poor. Elected law guarantees community to crisis benefits paying little respect to the capacity to pay. Those without health protection scope are relied upon to pay secretly for therapeutic administrations. Health protection is costly and hospital expenses are overwhelmingly the most well known explanation behind individual liquidation in the United States.

The Bismarck system was first employed in 1883 by Prussian Chancellor Otto von Bismarck. In this system, insurance is mandated by the government and is typically sold on a non profit basis. In many cases, employers and employees finance insurers through payroll deduction. In a pure Bismarck system, access to insurance is seen as a right solely predicated on labor status. The system attempts to cover all working citizens, meaning patients cannot be excluded from insurance due to pre existing conditions. While care is privatized, it is closely regulated by the state through fixed procedure pricing. This means that most insurance claims are reimbursed without challenge, creating a low administrative burden.

The national insurance model shares and mixes elements from both the Bismarck and Beveridge models. The emergence of the National Health Insurance model is cited as a response to the challenges presented by the traditional Bismarck and Beveridge systems. For instance, it is difficult for Bismarck Systems to contend with aging populations, as these demographics are less economically active. Ultimately, this model has more flexibility than a traditional Bismarck or Beveridge model, as it can pull effective practices from both systems as needed. This model maintains private providers, but payment comes directly from the government. Insurance plans control costs by paying for limited services. In some instances, citizens can opt out of public insurance for private insurance plans. However, large public insurance programs provide the government with bargaining power, allowing them to drive down prices for certain services and medication. In Canada, for instance, drug prices have been extensively lowered by the Patented Medicine Prices Review Board. Examples of this model can be found in Canada, Taiwan, and South Korea.

In areas with low levels of government stability or poverty, there is often no mechanism for ensuring that health costs are covered by a party other than the individual. In this case, patients must pay for services on their own. The UK National Health System creates excellent patient outcomes and mandates universal coverage but also has large lag times for treatment. Critics argue that reforms brought about by the Health and Social Care Act 2012 only proved to fragment the system, leading to high regulatory burden and long treatment delays. In his review of NHS leadership in 2015, Sir Stuart Rose concluded that "the NHS is drowning in bureaucracy."